{"organizations": [], "uuid": "62f527eaf5c2b0c05bc9e5abbb999952aba4295e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-aptevo-therapeutics-reports-2017-f/brief-aptevo-therapeutics-reports-2017-financial-results-and-provides-business-update-idUSASC09S0L", "country": "US", "domain_rank": 408, "title": "BRIEF-Aptevo Therapeutics Reports 2017 Financial Results And Provides Business Update", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-13T15:18:00.000+02:00", "replies_count": 0, "uuid": "62f527eaf5c2b0c05bc9e5abbb999952aba4295e"}, "author": "", "url": "https://www.reuters.com/article/brief-aptevo-therapeutics-reports-2017-f/brief-aptevo-therapeutics-reports-2017-financial-results-and-provides-business-update-idUSASC09S0L", "ord_in_thread": 0, "title": "BRIEF-Aptevo Therapeutics Reports 2017 Financial Results And Provides Business Update", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-aptevo therapeutics", "sentiment": "negative"}, {"name": "aptevo therapeutics inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 13, 2018 / 1:18 PM / Updated 26 minutes ago BRIEF-Aptevo Therapeutics Reports 2017 Financial Results And Provides Business Update Reuters Staff March 13 (Reuters) - Aptevo Therapeutics Inc: * APTEVO THERAPEUTICS REPORTS 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE * APTEVO - ‍HAD CASH, CASH EQUIVALENTS, SHORT-TERM INVESTMENTS AS OF DEC 31, 2017 TOTALING $91.2 MILLION​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-13T15:18:00.000+02:00", "crawled": "2018-03-13T15:57:56.009+02:00", "highlightTitle": ""}